Top Markets
#1 Islamic Coin Islamic Coin +154.37%
#2 PulseChain PulseChain +51.62%
#3 BOOK OF MEME BOOK OF MEME +40.64%
#4 DogBull DogBull +34.45%
#5 Ergo Ergo +18.71%
#6 Nockchain Nockchain +18.33%
#7 ORDI ORDI +17.36%
#8 rsERG rsERG +16.41%
#9 RedStone RedStone +16.37%
#10 Victoria VR Victoria VR +15.68%
Coin of the day
Islamic Coin Islamic Coin
Paramètres
Langue
FRANçAIS
Devise
USD
Thème
Grace Therapeutics, Inc. Grace Therapeutics, Inc.

Grace Therapeutics, Inc.

GRCE
Classement en actions #27036
Grace Therapeutics, Inc. specializes in the creation and commercialization of... Grace Therapeutics, Inc. specializes in the creation and commercialization of pharmaceutical products, primarily targeting uncommon and neglected diseases, with operations centered in Canada. The company's most advanced experimental treatment is GTX-104, an intravenous infusion designed to address subarachnoid hemorrhage. Its development pipeline further includes GTX-102, an oral mucosal betamethasone spray intended for the management of ataxia-telangiectasia, and GTX-101, a topical bioadhesive film-forming bupivacaine spray for postherpetic neuralgia. Established in 2002, the enterprise previously operated under the name Acasti Pharma Inc., before officially adopting Grace Therapeutics, Inc. in October 2024. The company's main offices are located in Princeton, New Jersey.
Prix de l'action
$2.18
Dernière synchronisation: 2026-08-19
Capitalisation boursière
$35.55M
Changement (1 jour)
2.57%
Changement (1 an)
-33.19%
Pays
US
Échange Grace Therapeutics, Inc. (GRCE)

Catégorie

Healthcare
Historique du prix de l'action pour Grace Therapeutics, Inc. (GRCE)
Prix de clôture le plus élevé : $2.13 le 2026-08-01

Prix de clôture le plus bas : $3.24 le 2024-10-01
Historique du prix de l'action de Grace Therapeutics, Inc. de 2024 à 2026
Performance annuelle du prix de l'action
Année Performance
2026 (TTM) -5.78%
2025 -13.39%
2024 0.00%
Prix de l'action pour des entreprises similaires ou concurrentes
Entreprise Prix de l'action Variation 1a% Pays
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $552.07 39.99%
US
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $168.77 527.63%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $1.03K 56.22%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $120.74 -14.98%
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $758.75 6.61%
CH